Timing clarification: Cognizant is scheduled to release Q2 results today, Wednesday, July 29, 2026, before the U.S. market opens, rather than tomorrow. The conference call is scheduled for 8:30 a.m. ET. (investors.cognizant.com)
This is less a quarter about whether Cognizant can beat a relatively achievable revenue target and more a test of whether management can defend its full-year outlook amid deteriorating sentiment toward IT services.
The stock closed July 28 at approximately $50.33, down about 38% from the start of 2026, despite rebounding roughly 30% from its late-June low. Much of the sector has sold off on concerns that:
Cognizant enters the report with better bookings momentum than many peers, but investors will want evidence that these bookings can translate into organic growth and earnings—not merely long-duration contract value.
| Metric | Q2 expectation / guidance | Prior-year Q2 |
|---|---|---|
| Revenue | Street: ~$5.49B | $5.245B |
| Reported revenue growth | ~4.7% | 8.1% |
| Constant-currency revenue guidance | 3.2%–4.7% | 7.2% actual |
| Reported revenue guidance | $5.45B–$5.52B | — |
| Adjusted EPS | Street: ~$1.38 | $1.31 |
| Adjusted EPS growth | ~5% | 12% |
| FY26 constant-currency growth guidance | 4.0%–6.5% | — |
| FY26 adjusted operating-margin guidance | 16.0%–16.2% | 15.8% FY25 |
| FY26 adjusted EPS guidance | $5.63–$5.77 | $5.28 FY25 |
The revenue consensus sits in the upper half of management's range, so a result near the midpoint may technically satisfy guidance but still feel soft. A cleaner outcome would be revenue of at least $5.50 billion, adjusted EPS above $1.38, and maintenance of the full-year outlook.
At the July 28 share price, the midpoint of the existing $5.63–$5.77 EPS guide implies a valuation of roughly 8.8 times 2026 adjusted EPS. That is inexpensive if earnings remain durable, but the multiple also reflects skepticism over the industry's long-term economics.
Q1 revenue was $5.413 billion. If Q2 lands at consensus, first-half revenue would be approximately $10.90 billion.
To reach the midpoint of full-year guidance, Cognizant would then need roughly $11.47 billion of second-half revenue, or about $5.74 billion per quarter. That requires a meaningful acceleration from Q2, supported by:
Management explicitly said last quarter that the midpoint assumed a better second-half discretionary environment than it was seeing in Q2. That assumption is now the largest near-term risk to guidance.
Recent peer results are mixed rather than reassuring. Wipro reported just 0.9% constant-currency IT-services growth, a sequential decline, and guided the following quarter to between a 1.5% decline and 0.5% growth. Infosys produced positive constant-currency growth and strong large-deal wins, but reduced its annual growth outlook. The read-through is that cost-takeout and large-deal demand remain available, while broad discretionary recovery is still elusive. (wipro.com)
A reduction in the top end might already be partly anticipated. A cut to the midpoint or an outlook implying weak organic growth would be more damaging.
Q1 was strong:
Management also said large-deal TCV increased more than 70%. (investors.cognizant.com)
The caveat is that annual contract value was flat because deal duration increased. That means headline TCV can look strong while near-term revenue contribution remains limited.
Investors should focus on:
Best signal: strong bookings accompanied by improving ACV and explicit revenue-conversion commentary.
Weak signal: another large TCV number driven primarily by longer contracts, with little change in near-term revenue visibility.
Cognizant's Q2 constant-currency guide includes approximately 150 basis points of acquisition contribution, including a partial quarter from Astreya.
That implies underlying organic growth may be only around 1.7%–3.2% before considering the effects of third-party product revenue. Product resale can also make reported growth stronger while depressing gross margin.
Investors should distinguish among:
A revenue beat driven mostly by acquisitions or low-margin product sales would be lower quality than a beat from core services.
Financial Services was the clear Q1 standout, growing more than 10% in constant currency and representing about 30% of company revenue. Cognizant cited healthy discretionary spending as well as large-deal ramps across banking and insurance.
The central question is whether that momentum continued through Q2. Continued high-single-digit or double-digit growth would materially support the full-year outlook.
Health Sciences is more complicated. Reported Q1 performance was affected by lower third-party product revenue; excluding that factor, management said services growth was closer to the company average. Investors should look for:
A healthy Financial Services result paired with stabilizing healthcare would substantially improve the earnings mix.
Project Leap is intended to redesign Cognizant's delivery model around AI-enabled teams, a broader entry-level talent base and a less top-heavy employee pyramid.
Management expects:
The program allowed Cognizant to raise its adjusted operating-margin outlook to 16.0%–16.2%, representing 20–40 basis points of expansion. (investors.cognizant.com)
Key questions include:
Q1 gross margin fell 80 basis points because of compensation, bench investment and lower-margin integrated offerings, even though adjusted operating margin expanded slightly. Gross-margin stabilization would therefore be an important positive.
Management's core argument is that Cognizant can become an “AI builder” rather than be displaced by AI. It reported more than 5,000 AI engagements in Q1, up from roughly 4,000 at year-end, and said nearly 40% of its code was AI-assisted.
The strategy has three broad components:
The market needs more than engagement counts. It needs evidence that AI produces:
Particularly important will be management's commentary on AI-infused rate cards and token-based pricing. Cognizant argues it can share productivity with customers while retaining part of the benefit. If competitive bidding forces most savings back to customers, the long-term margin case weakens.
Cognizant is using acquisitions to expand its AI-related stack:
Astreya should make a partial contribution in Q2 and a full contribution beginning in Q3. The strategic logic is credible because AI infrastructure spending can generate managed-services demand around cloud, data centers and workplace technology.
Still, investors should assess:
Q1 free cash flow was only about $198 million, reflecting seasonal bonus payments and working-capital usage. DSO increased to 84 days.
Management maintained full-year free-cash-flow conversion guidance of 90%–100% of net income and plans to return approximately $1.6 billion to shareholders in 2026, including $1 billion of repurchases.
Items to monitor:
At the current valuation, repurchases could be meaningfully accretive, assuming the earnings base is sustainable.
A constructive report would likely include:
That combination could support further multiple recovery because the shares already discount significant structural deterioration.
The stock reaction may depend more on Q3 guidance and the credibility of the second-half ramp than on the reported Q2 numbers.
The most concerning combination would be:
The numerical bar for Q2 is not especially demanding. The more consequential test is whether Cognizant can demonstrate that its strong bookings are converting into organic growth, sustainable margins and cash flow in an environment where IT-services demand remains uneven and AI is challenging traditional labor-based economics.
The most important combination is:
Q3 sequential growth + unchanged full-year guidance + stable margins + credible organic AI monetization.
If Cognizant delivers that, the current sub-9-times earnings valuation may look overly pessimistic. If management reduces the second-half growth outlook or cannot separate organic progress from acquisitions and product resale, the market is likely to continue treating the stock as a structurally challenged value name rather than an AI-enabled turnaround.